Online citations, reference lists, and bibliographies.
← Back to Search

Mitochondrial Dysfunction In Chronic Fatigue Syndrome

B. Chazotte
Published 2002 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Understanding of mitochondrial dysfunction in CFS will clearly benefit from more study. Our findings warrant detailed studies on larger patient and control populations. The siting of mitochondrial impairment may lead to approaches for alleviating some of the symptoms of CFS. Studies on the effects of cytokines on cellular and mitochondrial bioenergetics are important to see whether cytokines or similar molecules are involved in linking CFS immune disturbances to mitochondrial dysfunction, and to better understand the consequences of cytokine therapies for cancer and viral infection.
This paper references
10.1016/0098-2997(80)90005-9
Mitochondria and disease
E. Carafoli (1980)
Decreased natural killer cell activity in atopic eczema.
T. J. Hall (1985)
10.1203/00006450-198507000-00007
Genetic Deficiency of Medium-Chain Acyl Coenzyme A Dehydrogenase: Studies in Cultured Skin Fibroblasts and Peripheral Mononuclear Leukocytes
P. M. Coates (1985)
10.1136/jnnp.48.7.691
Electrophysiological studies in the post-viral fatigue syndrome.
G. Jamal (1985)
Genetic deficiency
P. M. Coates (1985)
10.2307/2289268
Biostatistical Analysis (2nd ed.).
T. Breen (1986)
Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.
M. Caligiuri (1987)
10.1016/S0140-6736(87)91319-5
INTERFERONS AS MEDIATORS OF PSYCHIATRIC MORBIDITY An Investigation in a Trial of Recombinant α-Interferon in Hepatitis-B Carriers
E. M. Mcdonald (1987)
10.1093/BRAIN/111.5.1009
The cerebral metabolism of glucose and oxygen measured with positron tomography in patients with mitochondrial diseases.
R. Frackowiak (1988)
10.1016/S0140-6736(88)90029-3
INTERFERON PRODUCTION IN POSTVIRAL FATIGUE SYNDROME
A. Lever (1988)
10.1093/INFDIS/157.3.405
The chronic mononucleosis syndrome.
S. Straus (1988)
10.7326/0003-4819-108-3-387
Chronic fatigue syndrome: a working case definition.
G. Holmes (1988)
Postviral fatigue syndrome.
P. O. Behan (1988)
10.1016/S0140-6736(88)90329-7
MYALGIC ENCEPHALOMYELITIS AND ALPHA-INTERFERON
D. Ho-Yen (1988)
Interferon production in postviral
A.M.L. Lever (1988)
10.1378/CHEST.95.4.779
Cardiac function at rest and with exercise in the chronic fatigue syndrome.
T. Montague (1989)
10.1142/9781848161665_0019
Mitochondrial myopathies.
A. Schapira (1989)
The muscle in fibromyalgia--a review of Swedish studies.
A. Bengtsson (1989)
Cardiac function at rest
T. J. Montague (1989)
Acyl-CoA dehydrogenase deficiencies, in Metabolic Bases
C. R. Roe (1989)
10.1111/J.1432-1033.1990.TB15632.X
Analysis of the membrane potential of rat- and mouse-liver mitochondria by flow cytometry and possible applications.
P. Petit (1990)
10.1128/jcm.28.6.1403-1410.1990
Immunologic abnormalities in chronic fatigue syndrome
N. Klimas (1990)
10.1007/978-1-4615-7133-9
Handbook of Biological Confocal Microscopy
J. Pawley (1990)
The Ca2+ second messenger system and interleukin-1-alpha modulation of hepatic gene transcription and mitochondrial fat oxidation.
R. Barke (1991)
10.1093/INFDIS/164.5.1023
Cytokine levels in serum and cerebrospinal fluid in patients with chronic fatigue syndrome and control subjects.
A. Lloyd (1991)
10.1093/CLINIDS/13.SUPPLEMENT_1.S26
Serologic and immunologic responses in chronic fatigue syndrome with emphasis on the Epstein-Barr virus.
J. Jones (1991)
10.1093/CLINIDS/13.SUPPLEMENT_1.S45
Cognitive and mood-state changes in patients with chronic fatigue syndrome.
J. Grafman (1991)
10.1093/CLINIDS/13.SUPPLEMENT_1.S12
Review of laboratory findings for patients with chronic fatigue syndrome.
D. Buchwald (1991)
Post-Viral Fatigue Syndrome
R. Jenkins (1991)
Laboratory abnormalities in chronic fatigue syndrome, in Post Viral Fatigue Syndrome
D. Buchwald (1991)
Cytokine levels in serum
A. Lloyd (1991)
The second messenger system and interleukin-I-alpha
R. A. Barke (1991)
10.1001/ARCHNEUR.1992.00530260058020
The neuropsychological features of mitochondrial myopathies and encephalomyopathies.
L. Kartsounis (1992)
10.1016/0003-9861(92)90161-O
Tumor necrosis factor induced oxidative stress in isolated mouse hepatocytes.
G. Adamson (1992)
10.1161/01.RES.71.5.1268
Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells.
Y. Geng (1992)
10.1080/21548331.1992.11705493
Chronic fatigue syndrome.
W. Cho (1992)
10.1146/ANNUREV.BI.61.070192.005523
Diseases of the mitochondrial DNA.
D. Wallace (1992)
10.1378/CHEST.102.6.1716
Skeletal muscle metabolism in the chronic fatigue syndrome. In vivo assessment by 31P nuclear magnetic resonance spectroscopy.
R. Wong (1992)
The diagnosis of chronic fatigue syndrome: An assertive approach, CFIDS
P. Cheney (1992)
Clinical observations of CNS dysfunction in post-infectious, acute onset
B. M. Hyde (1992)
syndrome: A comprehensive approach to its definition and study, Ann
Y.-j (1992)
10.4135/9781412952484.n129
Chronic fatigue syndrome
G. Bock (1993)
10.1016/B978-0-08-057139-3.50016-8
12 – LASER SCANNING CONFOCAL MICROSCOPY OF LIVING CELLS
J. Lemasters (1993)
10.1002/9780470514382.CH6
Epidemiology of chronic fatigue syndrome: the Centers for Disease Control Study.
W. Gunn (2007)
10.1002/9780470514382
Ciba Foundation Symposium 173 - Chronic Fatigue Syndrome
G. Bock (1993)
10.1038/jcbfm.1993.61
Defective Brain Energy Metabolism Shown by in vivo 31P MR Spectroscopy in 28 Patients with Mitochondrial Cytopathies
Bruno Barbiroli (1993)
10.1016/B978-0-12-461205-1.50040-0
33 – Use of Fluorescent Probes to Monitor Mitochondrial Membrane Potential in Isolated Mitochondria, Cell Suspensions, and Cultured Cells
J. Lemasters (1993)
10.1006/CLIN.1993.1178
Low NK syndrome and its relationship to chronic fatigue syndrome.
T. Aoki (1993)
10.1016/0006-3223(93)90100-R
Memory deficits associated with chronic fatigue immune dysfunction syndrome
C. Sandman (1993)
10.1016/0022-510X(93)90276-5
A controlled study of brain magnetic resonance imaging in patients with the chronic fatigue syndrome
B. Natelson (1993)
Optical microscopy : emerging methods and applications
B. Herman (1993)
Memory deficits associated with
C. A. Sandman (1993)
Epidemiology Chronic Fatigue Syndrome: The Centers
W. J. Gunn (1993)
1993b, SPECT imaging of the brain: Comparison of findings in patients with chronic fatigue
imaging (1993)
Low NK syndrome
hepatocytes (1993)
Laser scanning confocal
J. J. Lemasters (1993)
[Chronic fatigue syndrome--a controlled cross-sectional study].
Å. Rasmussen (1994)
10.2214/AJR.162.4.8141022
SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression.
R. Schwartz (1994)
10.1093/CLINIDS/18.SUPPLEMENT_1.S62
Acylcarnitine deficiency in chronic fatigue syndrome.
H. Kuratsune (1994)
10.1002/1097-0142(19941115)74:10<2850::AID-CNCR2820741018>3.0.CO;2-T
Cardiotoxicity as a dose‐limiting factor in a schedule of high dose bolus therapy with interleukin‐2 and alpha‐interferon. An unexpectedly frequent complication
W. Kruit (1994)
10.1093/CLINIDS/18.SUPPLEMENT_1.S157
Decreased natural killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome.
E. Ojo-Amaize (1994)
10.7326/0003-4819-121-12-199412150-00009
The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study
K. Fukuda (1994)
10.2214/AJR.162.4.8141020
Detection of intracranial abnormalities in patients with chronic fatigue syndrome: comparison of MR imaging and SPECT.
R. Schwartz (1994)
10.3171/jns.2004.100.3.0575
Cerebral metabolism.
A. Ritter (1994)
10.1016/S0006-3495(94)80904-X
Distribution of electrical potential, pH, free Ca2+, and volume inside cultured adult rabbit cardiac myocytes during chemical hypoxia: a multiparameter digitized confocal microscopic study.
E. Chacón (1994)
10.1093/CLINIDS/18.SUPPLEMENT_1.S117
Viral studies of chronic fatigue syndrome.
J. Levy (1994)
Distribution of electrical potential, pH, free and volume inside cultured adult rabbit myocytes
E. Chacon (1994)
Chronic fatigue syndrome: A controlled cross-sectional study, J. Rheumatol
A. Wiik (1994)
Cardiotoxicity as a doselimiting factor in a schedule of high dose bolus therapy with interleukin - 2 and alphainterferon
W. H. Kruit (1994)
10.1136/bmj.311.7004.544
Exercise responses and psychiatric disorder in chronic fatigue syndrome
R. Lane (1995)
10.1016/S0140-6736(95)90525-1
Is neurally mediated hypotension an unrecognised cause of chronic fatigue?
P. Rowe (1995)
10.1016/0925-4439(95)00039-7
The treatment of mitochondrial myopathies and encephalomyopathies.
P. Peterson (1995)
Is neurally mediated hypotension an unrecognised cause of chronic fatigue?
R. Walden (1995)
10.1093/HMG/4.4.751
Unusual pattern of mitochondrial DNA deletions in skeletal muscle of an adult human with chronic fatigue syndrome.
C. Zhang (1995)
10.7326/0003-4819-123-2-199507150-00001
Chronic Fatigue and the Chronic Fatigue Syndrome: Prevalence in a Pacific Northwest Health Care System
Dedra Buchwald (1995)
Exercise responses and psychiatric
R.J.M. Lane (1995)
Handbook of Biological Confocal Microscopy, 2nd ed., Plenum
J B.Pawley (1995)
Management strategies for chronic fatigue syndrome, Fed
K. Fukuda (1995)
10.1300/J094V02N03_06
Chronic fatigue syndrome.
S. Straus (1996)
10.1002/(SICI)1097-4598(199605)19:5<621::AID-MUS10>3.0.CO;2-Q
Reduced oxidative muscle metabolism in chronic fatigue syndrome
K. McCully (1996)
Mechanisms of interleukin-2-induced hepatic toxicity.
K. Nakagawa (1996)
10.1006/BMME.1996.0012
Preliminary determination of a molecular basis of chronic fatigue syndrome.
N. Mcgregor (1996)
Quantitative analyses of membrane potential of mitochondria in individual living human cells related to chronic illness
B. Chazotte (1996)
10.1300/J092V02N01_07
Immunologic Abnormalities in Chronic Fatigue Syndrome
U. Tirelli (1996)
Reduced oxidative metabolism in chronic
McCully (1996)
Preliminary determination of a molecular basis to chronic fatigue syndrome , Biochem
T. J. Montague (1996)
Quantitative analyses of membrane potential
B. Chazotte (1996)
Mechanisms of interleukin - 2 hepatic toxicity ,
B. H. Natelson (1996)
10.1111/j.1365-2796.1997.tb00019.x
Elevated apoptotic cell population in patients with chronic fatigue syndrome: the pivotal role of protein Kinase RNA
A. Vojdani (1997)
10.1159/000119325
Amantadine and L-carnitine treatment of Chronic Fatigue Syndrome.
A. Plioplys (1997)
10.1001/JAMA.1997.03550140071043
A 56-year-old woman with chronic fatigue syndrome.
A. Komaroff (1997)
Surveillance for chronic fatigue syndrome--four U.S. cities, September 1989 through August 1993.
M. Reyes (1997)
A 56-year-old woman with chronic fatigue syndrome, JAMA 278:1179–1185
A. L. Komaroff (1997)
Elevated apoptotic cell
A. Vojdani (1997)
Interleukin interleukin-1 receptor antagonist, and soluble interleukin-l receptor type II
A L. (1997)
10.1146/ANNUREV.MED.49.1.1
Chronic fatigue syndrome: an update.
A. Komaroff (1998)
10.1136/jnnp.64.3.362
Muscle fibre characteristics and lactate responses to exercise in chronic fatigue syndrome
R. Lane (1998)
10.1212/WNL.51.1.331-A
Chronic Fatigue Syndrome
T. Sabin (1998)
10.1111/J.1749-6632.1998.TB09607.X
Evidence for and Pathophysiologic Implications of Hypothalamic‐Pituitary‐Adrenal Axis Dysregulation in Fibromyalgia and Chronic Fatigue Syndrome
M. Demitrack (1998)
10.1016/S0960-8966(98)00021-2
Heterogeneity in chronic fatigue syndrome: evidence from magnetic resonance spectroscopy of muscle
R. Lane (1998)
Chronic fatigue syndrome: A working case definition, Ann
T R. (1998)
Heterogeneity in chronic fatigue
R.J.M. Lane (1998)
Using membrane potential to follow cytokinc effects on mitochondria
B. Chazotte (1999)
10.1007/BF00294431
Mitochondrial abnormalities in the postviral fatigue syndrome
W. Behan (2004)
10.1159/000075315
Neuroendocrine Aspects of Chronic Fatigue Syndrome
D. Papanicolaou (2004)
10.1023/A:1027314713231
Interleukin-1β, Interleukin-1 Receptor Antagonist, and Soluble Interleukin-1 Receptor Type II Secretion in Chronic Fatigue Syndrome
J. Cannon (1997)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar